Which 2019 pharmaceutical merger created one of the largest specialty drug companies in the world, combining treatments for cancer, immunology, and rare diseases?

The medical industry has seen numerous significant mergers and acquisitions that have reshaped the pharmaceutical landscape. These strategic moves have created some of the largest healthcare companies in the world, combining research capabilities, product portfolios, and market reach. Test your knowledge about one of the biggest pharmaceutical mergers in recent history that dramatically impacted the medical product marketplace.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Bristol-Myers Squibb's acquisition of Celgene ($74 billion)
Takeda's acquisition of Shire ($62 billion)
AbbVie's acquisition of Allergan ($63 billion)
Novartis's acquisition of AveXis ($8.7 billion)